A detailed history of Ubs Group Ag transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 29,227 shares of BIO stock, worth $9.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,227
Previous 52,910 44.76%
Holding current value
$9.67 Million
Previous $14.5 Million 32.33%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$263.97 - $344.64 $6.25 Million - $8.16 Million
-23,683 Reduced 44.76%
29,227 $9.78 Million
Q2 2024

Aug 13, 2024

SELL
$268.26 - $339.48 $105,157 - $133,076
-392 Reduced 0.74%
52,910 $14.5 Million
Q1 2024

May 13, 2024

BUY
$304.11 - $351.99 $5.41 Million - $6.27 Million
17,806 Added 50.16%
53,302 $18.4 Million
Q4 2023

Feb 09, 2024

SELL
$269.37 - $365.04 $1.19 Million - $1.62 Million
-4,431 Reduced 11.1%
35,496 $11.5 Million
Q3 2023

Nov 09, 2023

BUY
$350.25 - $422.63 $2.89 Million - $3.49 Million
8,262 Added 26.09%
39,927 $14.3 Million
Q2 2023

Aug 11, 2023

BUY
$359.49 - $486.4 $4.92 Million - $6.66 Million
13,685 Added 76.11%
31,665 $12 Million
Q1 2023

May 12, 2023

BUY
$418.69 - $503.0 $1.84 Million - $2.21 Million
4,401 Added 32.41%
17,980 $8.61 Million
Q4 2022

Feb 08, 2023

BUY
$351.71 - $456.01 $2.56 Million - $3.32 Million
7,281 Added 115.61%
13,579 $5.71 Million
Q3 2022

Nov 10, 2022

SELL
$412.59 - $563.26 $545,443 - $744,629
-1,322 Reduced 17.35%
6,298 $2.63 Million
Q2 2022

Aug 10, 2022

SELL
$463.67 - $597.16 $4.34 Million - $5.59 Million
-9,363 Reduced 55.13%
7,620 $3.77 Million
Q1 2022

May 16, 2022

SELL
$524.57 - $735.42 $738,069 - $1.03 Million
-1,407 Reduced 7.65%
16,983 $9.57 Million
Q4 2021

Feb 14, 2022

SELL
$708.84 - $794.68 $2.16 Million - $2.42 Million
-3,044 Reduced 14.2%
18,390 $13.9 Million
Q3 2021

Nov 15, 2021

BUY
$657.71 - $825.77 $1.72 Million - $2.16 Million
2,618 Added 13.91%
21,434 $16 Million
Q2 2021

Aug 13, 2021

SELL
$576.64 - $649.04 $4.91 Million - $5.52 Million
-8,512 Reduced 31.15%
18,816 $12.1 Million
Q1 2021

May 12, 2021

BUY
$547.01 - $662.35 $4.09 Million - $4.95 Million
7,468 Added 37.6%
27,328 $15.6 Million
Q4 2020

Feb 11, 2021

SELL
$510.68 - $643.45 $8.38 Million - $10.6 Million
-16,417 Reduced 45.25%
19,860 $11.6 Million
Q3 2020

Nov 12, 2020

SELL
$454.43 - $535.6 $8.74 Million - $10.3 Million
-19,228 Reduced 34.64%
36,277 $18.7 Million
Q2 2020

Jul 31, 2020

SELL
$334.87 - $493.06 $7.04 Million - $10.4 Million
-21,029 Reduced 27.48%
55,505 $25.1 Million
Q1 2020

May 01, 2020

SELL
$320.01 - $409.07 $761,303 - $973,177
-2,379 Reduced 3.01%
76,534 $26.8 Million
Q4 2019

Feb 14, 2020

BUY
$319.73 - $374.2 $3.43 Million - $4.01 Million
10,719 Added 15.72%
78,913 $29.2 Million
Q3 2019

Nov 14, 2019

SELL
$304.55 - $345.24 $5.55 Million - $6.29 Million
-18,219 Reduced 21.08%
68,194 $22.7 Million
Q2 2019

Aug 14, 2019

BUY
$286.93 - $312.59 $663,095 - $722,395
2,311 Added 2.75%
86,413 $27 Million
Q1 2019

May 14, 2019

SELL
$224.3 - $317.41 $8.81 Million - $12.5 Million
-39,269 Reduced 31.83%
84,102 $25.7 Million
Q4 2018

Feb 14, 2019

BUY
$220.1 - $309.0 $7.09 Million - $9.96 Million
32,231 Added 35.36%
123,371 $28.6 Million
Q3 2018

Nov 14, 2018

BUY
$289.28 - $326.15 $5.31 Million - $5.98 Million
18,346 Added 25.2%
91,140 $28.5 Million
Q2 2018

Aug 14, 2018

BUY
$244.1 - $303.88 $11.2 Million - $14 Million
45,911 Added 170.78%
72,794 $21 Million
Q1 2018

May 15, 2018

SELL
$233.97 - $274.11 $80,719 - $94,567
-345 Reduced 1.27%
26,883 $6.72 Million
Q4 2017

Feb 14, 2018

BUY
$216.94 - $271.3 $473,796 - $592,519
2,184 Added 8.72%
27,228 $6.5 Million
Q3 2017

Nov 14, 2017

SELL
$212.27 - $242.28 $280,833 - $320,536
-1,323 Reduced 5.02%
25,044 $5.57 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-642 Reduced 2.38%
26,367 $5.97 Million
Q1 2017

Nov 14, 2017

BUY
N/A
27,009
27,009 $5.38 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.15B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.